Nasab Susan, Gough Ethan K, Nylander Elisabeth, Borahay Mostafa, Segars James, Baker Valerie, Wang Xiaobin, Cameron Katherine
medRxiv. 2024 Mar 7:2024.03.05.24303824. doi: 10.1101/2024.03.05.24303824.
In this study the presence of uterine fibroids was significantly associated with an increased risk of development of hypertensive disorders of pregnancy even when accounting for age and BMI in meta-regression. This finding has potential implications for risk stratification and monitoring for hypertension during pregnancy in this population.
To examine the association between uterine fibroids and the development of hypertensive disorders in pregnancy.
Cochrane, Embase, PubMed, MEDLINE, Scopus, and Web of Science databases were searched from inception through April 2023.
Cohort, case-control, or case series studies including uterine fibroid status and hypertensive disorders of pregnancy status were included. The comparison group was pregnant women without uterine fibroids. Inverse-variance weighted random effects models were used to pool RR and OR estimates separately. Age and BMI were explored as potential sources of heterogeneity using inverse-variance weighted meta-regression.
Hypertensive disorders of pregnancy (HDP) defined as gestational hypertension, pre-eclampsia, eclampsia, superimposed preeclampsia, or hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome.
A total of 17 studies were included (Total N=1,374,395 participants, N=64,968 with uterine fibroids). Thirteen studies were retrospective cohorts and four were case-control studies. Women with uterine fibroids had a significantly higher risk of hypertensive disorders in pregnancy compared to women without uterine fibroids with RR 1.74 (95% CI 1.33-2.27, p<0.01), and OR 2.87 (95% CI 1.38-5.97, p<0.01), in cohort studies and case-control studies, respectively. In meta-regression analyses, age did not significantly change the positive association between uterine fibroids and hypertensive disorders in pregnancy.
Uterine fibroids were associated with an increased risk of hypertensive disorders of pregnancy when all available literature was synthesized, including when shared risk factors are examined in meta-regression analyses.
If confirmed in future studies, investigations into the mechanisms of this association are needed as this finding potentially has implications for risk stratification and monitoring for hypertensive disorders of pregnancy in this population.
PROSPERO, ID # 331528.
在本研究中,即使在Meta回归中考虑了年龄和体重指数(BMI),子宫肌瘤的存在仍与妊娠期高血压疾病发生风险增加显著相关。这一发现对该人群妊娠期高血压的风险分层和监测具有潜在意义。
探讨子宫肌瘤与妊娠期高血压疾病发生之间的关联。
检索Cochrane、Embase、PubMed、MEDLINE、Scopus和Web of Science数据库,检索时间从建库至2023年4月。
纳入包括子宫肌瘤状态和妊娠期高血压疾病状态的队列研究、病例对照研究或病例系列研究。对照组为无子宫肌瘤的孕妇。采用逆方差加权随机效应模型分别汇总相对危险度(RR)和比值比(OR)估计值。使用逆方差加权Meta回归探讨年龄和BMI作为异质性的潜在来源。
妊娠期高血压疾病(HDP)定义为妊娠期高血压、子痫前期、子痫、叠加子痫前期或溶血、肝酶升高和血小板减少(HELLP)综合征。
共纳入17项研究(总样本量=1,374,395名参与者,子宫肌瘤患者64,968名)。13项为回顾性队列研究,4项为病例对照研究。在队列研究和病例对照研究中,与无子宫肌瘤的女性相比,有子宫肌瘤的女性发生妊娠期高血压疾病的风险显著更高,队列研究中RR为1.74(95%CI 1.33 - 2.27,p<0.01),病例对照研究中OR为2.87(95%CI 1.38 - 5.97,p<0.01)。在Meta回归分析中,年龄并未显著改变子宫肌瘤与妊娠期高血压疾病之间的正相关关系。
综合所有现有文献,包括在Meta回归分析中考察共同风险因素时,子宫肌瘤与妊娠期高血压疾病风险增加相关。
如果在未来研究中得到证实,需要对这种关联的机制进行研究,因为这一发现可能对该人群妊娠期高血压疾病的风险分层和监测有影响。
国际前瞻性系统评价注册库(PROSPERO),编号331528。